BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8904244)

  • 1. [Cystic fibrosis].
    Yoshimura K; Anzai C
    Nihon Rinsho; 1996 Mar; 54(3):825-33. PubMed ID: 8904244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective activation of cystic fibrosis transmembrane conductance regulator Cl- and HCO3- conductances.
    Reddy MM; Quinton PM
    JOP; 2001 Jul; 2(4 Suppl):212-8. PubMed ID: 11875262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of delta F508 cystic fibrosis transmembrane conductance regulator protein and related chloride transport properties in the gallbladder epithelium from cystic fibrosis patients.
    Dray-Charier N; Paul A; Scoazec JY; Veissière D; Mergey M; Capeau J; Soubrane O; Housset C
    Hepatology; 1999 Jun; 29(6):1624-34. PubMed ID: 10347100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystic fibrosis transmembrane conductance regulator (CFTR) and renal function.
    Stanton BA
    Wien Klin Wochenschr; 1997 Jun; 109(12-13):457-64. PubMed ID: 9261986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CFTR as cAMP-dependent chloride channels and as cAMP-dependent regulator of sodium channels].
    Tohyama M
    Nihon Rinsho; 1996 Feb; 54(2):429-33. PubMed ID: 8838092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between cystic fibrosis transmembrane conductance regulator, extracellular nucleotides and cystic fibrosis.
    Marcet B; Boeynaems JM
    Pharmacol Ther; 2006 Dec; 112(3):719-32. PubMed ID: 16828872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [From the laboratory to the clinic: CFTR and the therapeutic options for cystic fibrosis].
    Mayol J; Alvarez de Arcaya Vicente A; Arbeo Escolar AM; Peña Soria MJ; Alvarez Fernández-Represa J
    An Med Interna; 2000 Feb; 17(2):92-8. PubMed ID: 10829466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy.
    Hyde SC; Gill DR; Higgins CF; Trezise AE; MacVinish LJ; Cuthbert AW; Ratcliff R; Evans MJ; Colledge WH
    Nature; 1993 Mar; 362(6417):250-5. PubMed ID: 7681548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cystic fibrosis lung disease and its management].
    Hidaka N; Hidaka Y
    Nihon Rinsho; 1999 Sep; 57(9):2139-44. PubMed ID: 10497420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the mechanisms underlying CFTR channel activity, the molecular basis for cystic fibrosis and strategies for therapy.
    Kim Chiaw P; Eckford PD; Bear CE
    Essays Biochem; 2011 Sep; 50(1):233-48. PubMed ID: 21967060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CFTR protein and molecular mechanisms of pulmonary involvement in cystic fibrosis].
    Chinet T
    Rev Pneumol Clin; 1995; 51(3):122-9. PubMed ID: 7569573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functions of the cystic fibrosis transmembrane conductance regulator protein.
    Frizzell RA
    Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S54-8. PubMed ID: 7533606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rescuing cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by transcomplementation.
    Cormet-Boyaka E; Jablonsky M; Naren AP; Jackson PL; Muccio DD; Kirk KL
    Proc Natl Acad Sci U S A; 2004 May; 101(21):8221-6. PubMed ID: 15141088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cystic fibrosis: molecular update and clinical implications].
    Orozco L; Chávez M; Saldaña Y; Velázquez R; Carnevale A; González-del Angel A; Jiménez S
    Rev Invest Clin; 2006; 58(2):139-52. PubMed ID: 16827266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in CFTR associated with mild-disease-form Cl- channels with altered pore properties.
    Sheppard DN; Rich DP; Ostedgaard LS; Gregory RJ; Smith AE; Welsh MJ
    Nature; 1993 Mar; 362(6416):160-4. PubMed ID: 7680769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The cystic fibrosis gene, its product CFTR protein and its mutations].
    Goossens M; Fanen P; Costes B; Ghanem N
    Bull Acad Natl Med; 1993 Mar; 177(3):371-80; discussion 380-1. PubMed ID: 7689915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive.
    Denning GM; Anderson MP; Amara JF; Marshall J; Smith AE; Welsh MJ
    Nature; 1992 Aug; 358(6389):761-4. PubMed ID: 1380673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular repair of a defective CFTR protein in cystic fibrosis.
    Erlinger S
    Clin Res Hepatol Gastroenterol; 2011 Apr; 35(4):254-6. PubMed ID: 21349786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells.
    Rich DP; Anderson MP; Gregory RJ; Cheng SH; Paul S; Jefferson DM; McCann JD; Klinger KW; Smith AE; Welsh MJ
    Nature; 1990 Sep; 347(6291):358-63. PubMed ID: 1699126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation.
    Dalemans W; Barbry P; Champigny G; Jallat S; Dott K; Dreyer D; Crystal RG; Pavirani A; Lecocq JP; Lazdunski M
    Nature; 1991 Dec 19-26; 354(6354):526-8. PubMed ID: 1722027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.